AU6069296A - Production of outer membrane (OM) proteins in gram-positive bacteria and recovery of protective epitopes - Google Patents

Production of outer membrane (OM) proteins in gram-positive bacteria and recovery of protective epitopes

Info

Publication number
AU6069296A
AU6069296A AU60692/96A AU6069296A AU6069296A AU 6069296 A AU6069296 A AU 6069296A AU 60692/96 A AU60692/96 A AU 60692/96A AU 6069296 A AU6069296 A AU 6069296A AU 6069296 A AU6069296 A AU 6069296A
Authority
AU
Australia
Prior art keywords
gram
proteins
recovery
production
outer membrane
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU60692/96A
Inventor
Sarah Butcher
Ilona Idanpaan-Heikkila
Susanna Muttilainen
Marjatta Nurminen-Kalliokoski
Ritvaleena Puohiniemi
Kate Runeberg-Nyman
Matti Sarvas
Eva Wahlstrom
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Finnish National Public Health Institute
Original Assignee
Finnish National Public Health Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Finnish National Public Health Institute filed Critical Finnish National Public Health Institute
Publication of AU6069296A publication Critical patent/AU6069296A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/75—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Bacillus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU60692/96A 1990-07-06 1996-07-24 Production of outer membrane (OM) proteins in gram-positive bacteria and recovery of protective epitopes Abandoned AU6069296A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI903414A FI903414A (en) 1990-07-06 1990-07-06 PRODUKTION AV PROTEINER I GRAMPOSITIVA BAKTERIER.
FI903414 1990-07-06

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
AU81873/91A Division AU668075B2 (en) 1990-07-06 1991-07-05 Production of outer membrane (OM) proteins in gram-positive bacteria and recovery of protective epitopes

Publications (1)

Publication Number Publication Date
AU6069296A true AU6069296A (en) 1996-11-07

Family

ID=8530757

Family Applications (2)

Application Number Title Priority Date Filing Date
AU81873/91A Expired - Fee Related AU668075B2 (en) 1990-07-06 1991-07-05 Production of outer membrane (OM) proteins in gram-positive bacteria and recovery of protective epitopes
AU60692/96A Abandoned AU6069296A (en) 1990-07-06 1996-07-24 Production of outer membrane (OM) proteins in gram-positive bacteria and recovery of protective epitopes

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AU81873/91A Expired - Fee Related AU668075B2 (en) 1990-07-06 1991-07-05 Production of outer membrane (OM) proteins in gram-positive bacteria and recovery of protective epitopes

Country Status (8)

Country Link
EP (1) EP0538318A1 (en)
JP (1) JPH06511140A (en)
AU (2) AU668075B2 (en)
CA (1) CA2086761A1 (en)
FI (1) FI903414A (en)
IL (1) IL98727A0 (en)
WO (1) WO1992001001A1 (en)
ZA (1) ZA915234B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6153406A (en) * 1993-07-23 2000-11-28 North American Vaccine, Inc. Method for the high level expression, purification and refolding of the outer membrane protein P2 from Haemophilus influenzae type B
US5439808A (en) * 1993-07-23 1995-08-08 North American Vaccine, Inc. Method for the high level expression, purification and refolding of the outer membrane group B porin proteins from Neisseria meningitidis
DE4401419C1 (en) * 1994-01-19 1994-12-22 Forschungszentrum Juelich Gmbh Secretion of proteins of the outer membrane of Gram-negative bacteria by means of Gram-positive host organisms
US5747287A (en) * 1995-04-28 1998-05-05 North American Vaccine, Inc. Method for the high level expression, purification and refolding of the outer membrane group B porin proteins from Neisseria meningitidis
US5811102A (en) 1995-06-07 1998-09-22 National Research Council Of Canada Modified meningococcal polysaccharide conjugate vaccines
SE9702191D0 (en) * 1997-06-09 1997-06-09 Sven Pettersson Coposition and methods for the treatment of inflammatory dideases
FR2785293B1 (en) * 1998-10-30 2002-07-05 Pasteur Merieux Serums Vacc NUCLEIC ACIDS AND POLYPEPTIDES SPECIFIC TO NEISSERIA PATHOGENIC STRAINS

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2534529B2 (en) * 1986-07-24 1996-09-18 ブリティシュ・テレコミュニケ−ションズ・パブリック・リミテッド・カンパニ Radiation generator
NZ224065A (en) * 1987-03-30 1991-02-26 Texas A & M Univ Sys Vaccine against brucella abortus

Also Published As

Publication number Publication date
FI903414A (en) 1992-01-07
EP0538318A1 (en) 1993-04-28
AU668075B2 (en) 1996-04-26
ZA915234B (en) 1993-02-24
AU8187391A (en) 1992-02-04
JPH06511140A (en) 1994-12-15
CA2086761A1 (en) 1992-01-07
WO1992001001A1 (en) 1992-01-23
FI903414A0 (en) 1990-07-06
IL98727A0 (en) 1992-07-15

Similar Documents

Publication Publication Date Title
AU7869891A (en) Novel enzyme preparations and methods for their production
AU8550591A (en) Membrane separation system and methods of operating and cleaning such a system
AU1482888A (en) Membrane type artificial lung and production thereof
AU579323B2 (en) Vaccines based on membrane bound proteins and process for making them
AU3274693A (en) Composite membrane
AU3125693A (en) Microstructured membranes and methods for making same
AU648128B2 (en) Surface-modified support membrane and process therefor
AU639743B2 (en) Irrigation system and irrigation method
AU7416191A (en) Electrographic structure and process
AU1061695A (en) Shellfish culture and harvesting system
AU2487788A (en) Pathogenesis-related proteins in plants
AU4754490A (en) Heat-labile toxin b subunit fusion proteins
PL279555A1 (en) Method of directly, purposedly and reproducibly effecting genetical manipulation with bacteria b thuring
AU6069296A (en) Production of outer membrane (OM) proteins in gram-positive bacteria and recovery of protective epitopes
AU8867691A (en) Process for producing monohydrated beta-ferric oxide and improved process for producing ferrate employing beta-ferric oxide
AU8059391A (en) Method of making peptides
AU6176690A (en) Natural human anti-gamma interferon antibodies detected and purified by synthetic peptides
AU9157091A (en) Natamycin recovery
AU6936794A (en) Irrigation membrane material and irrigation method
AU8271191A (en) Indolonaphthyridines, their production and use
AU2191992A (en) Stiff fabric composite and method of making
AU5255493A (en) Viable cell-containing preparation and the preparation method thereof
AU625714B2 (en) Two degrees of freedom type control system
AU5396390A (en) Modified membrane
AU6359894A (en) Agricultural-chemical-producing endosymbiotic microorganisms and method of preparing and using same